Jefferies Analyst Says AbbVie Hepatitis C Price-War Fears Overblown By: Benzinga via Benzinga February 09, 2015 at 11:46 AM EST AbbVie Inc(NYSE: ABBV) shares are likely to rally with the expected near-term release of new data on two key drug candidates, ... Read More >> Related Stocks: AbbVie Gilead Sciences